About this trial
Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment tools that are both practical and predictive of fall risk is therefore essential. This study aimed to investigate the relationship between fall frequency and three balance assessment tools: the Biodex Balance System (objective), the Falls Efficacy Scale-International (FES-I) (self-reported), and the Mini-Balance Evaluation Systems Test (Mini-BESTest) (functional).
Methods: Patients with PD at Hoehn and Yahr stages 1-3 will be included in the study. Fall data will be collected using a fall diary, while objective balance will be assessed with the Biodex Balance System, functional performance will be evaluated with the Mini-BESTest, and self-reported balance confidence will be measured with the FES-I.
Eligibility criteria
Qualifiers
Age between 40 and 80 years old
Receiving stable dopaminergic treatment
No other neurological disorders besides PD
A Standardized Mini-Mental State Examination (MMSE) score >24
Disqualifiers
Having mental or physical impairments severe enough to hinder communication
Clinically unstable condition within the past month
Participation in a rehabilitation program within the last six months
Trial design
Treatments tested in this trial
- Not listed